Mako to release assays from Tchaga in coming weeks
Mako Gold Limited (ASX:MKG) has completed its latest reverse circulation (RC) drilling program at the Tchaga Prospect part of the company’s 224 square kilometre Napié Project in Côte d’Ivoire.
As a backdrop, Mako is earning up to a 75% interest in the Napié Project under a farm-in and joint venture agreement with Occidental Gold SARL, a subsidiary of West African gold miner Perseus Mining Limited (ASX/TSX:PRU).
Mako currently holds a 51% interest in the permit and is operator of the Napié Project which as can be seen below (red) is located in a region surrounded by multi-million ounce gold projects being operated by multinational mining groups.
Importantly, Mako has already had significant exploration success at the Tchaga Prospect, including drill intersections of 28 metres at 4.9 g/t gold and 25 metres at 3.4 g/t gold from 80 metres and 50 metres respectively.
It was the quality of these results that prompted management to prioritise Tchaga in planning a 19 hole drilling program across an area of 2100 metres.
Building towards establishing a maiden resource
As the Tchaga Prospect is associated with gold soil anomalies coincident with a long shear zone totalling more than 17 kilometres, results from this drilling campaign are much anticipated.
The company is focusing on the more advanced Tchaga Prospect to help move towards the delineation of a JORC compliant gold resource.
Current and previous drill results have confirmed the presence of multiple gold mineralised zones along a strike length of 1 kilometre as indicated below.
The purpose of the program is to demonstrate continuity of gold mineralisation within the 1 kilometre target area, which would increase confidence in the modelling of the mineralised trend.
Management said that assay results should be received by early December, a potential share price catalyst.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.